NeonMind Biosciences Inc. (NMDBF)
NeonMind Biosciences Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Oakville, ON, CA. The stock last traded at $0.01, up 0.00% on the session, giving a market capitalisation of $8,538. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of 0.0%. Its beta of -0.88 implies it has historically moved less than the broad market.
NeonMind Biosciences Inc. specializes in the research, formulation, and commercialization of medicinal and psychedelic fungi aimed at treating mental health conditions. The company is actively developing a line of psilocybin-derived products, featuring various mushroom-infused preparations, specifically tailored for weight loss and management. Originally incorporated in 2019 as Flourish Mushroom Labs Inc., it rebranded to NeonMind Biosciences Inc. in April 2020. Headquartered in Oakville, Canada, the company operates as a subsidiary of The Yield Growth Corp.
NeonMind Biosciences Inc. is most often compared with the following Healthcare names: